http://glamclinicdubai.ae/en/weight-loss/wegovy-injections/
Certainly! Here's a rewritten version of the article:

In Dubai and the wider UAE, drug pricing is subject to stringent government regulations that prioritize access to essential medicines, cost control in healthcare, and the promotion of innovative treatments. This regulatory framework significantly influences the pricing of drugs like Wegovy.

Government Regulations Shaping Drug Pricing:
The Ministry of Health and Prevention (MOHAP) is the primary federal authority overseeing drug pricing, with the Emirates Drug Establishment (EDE) taking on a key role in regulating medical products, including pricing.

Centralized Registration and Pricing Approval:
- Registration Requirement: All pharmaceutical products must undergo rigorous registration with MOHAP (now EDE) before being available for sale in the UAE.
- Pricing Submission: Manufacturers or local marketing authorization holders must submit proposed drug prices during registration, including pricing details from international markets.
- Drugs Pricing Committee: A dedicated committee within MOHAP (and soon EDE) evaluates proposed prices against set criteria before recommending final prices.

External Reference Pricing (ERP):
- Benchmarking Practice: The UAE employs ERP extensively, comparing new drug prices with a basket of reference countries to control pharmaceutical expenditure.
- Influence: The choice of reference countries and the pricing methodology directly impact the maximum approved price in the UAE, preventing significant price disparities.

Fixed Profit Margins:
- Regulated Margins: Maximum profit margins at different supply chain stages are legislated in the UAE, ensuring price consistency and preventing arbitrary price inflation.
- Price Stability: Fixed margins eliminate price variations across pharmacies and sellers, prohibiting unauthorized discounts to maintain market fairness.

Ministerial Decisions and Enforcement:
- Legally Binding Prices: Approved drug prices are officially published through Ministerial Decisions, with strict penalties for violations to ensure compliance.
- Labeling Requirement: Transparency is enhanced through price labeling on medical product packaging in warehouses and pharmacies.

Focus on Accessibility and Affordability:
- National Drug Policy: The UAE's National Drug Policy, led by the EDE, emphasizes equitable access to affordable essential drugs, influencing pricing decisions.
- Strategic Stock Management: EDE's mandate includes ensuring continuous availability of essential medicines to prevent supply-driven shortages and price hikes.

Impact on Wegovy Prices in Dubai:
- Managed Pricing: Wegovy's price in Dubai is regulated through negotiation and approval between Novo Nordisk (or its local agent) and UAE regulators.
- Balancing Objectives: Pricing regulations aim to incentivize innovation, ensure patient access, control healthcare spending, and maintain price transparency and consistency.

In summary, government regulations in the UAE, spearheaded by MOHAP and the EDE, play a crucial role in determining drug prices in Dubai. Through stringent registration, external reference pricing, fixed profit margins, and strict enforcement, these regulations seek to strike a balance between market viability and public health affordability for drugs like Wegovy.